首页> 外文期刊>Human cell: official journal of Human Cell Research Society >Establishment and characterization of human lingual squamous cell carcinoma cell lines designated Nialym derived from metastatic foci of lymph node, and Nialymx derived from transplanted tumor of Nialym cells
【24h】

Establishment and characterization of human lingual squamous cell carcinoma cell lines designated Nialym derived from metastatic foci of lymph node, and Nialymx derived from transplanted tumor of Nialym cells

机译:来源于淋巴结转移灶的人舌鳞状细胞癌细胞株Nialym的建立和特性以及来源于Nialym细胞移植瘤的Nialymx的建立

获取原文
获取原文并翻译 | 示例
           

摘要

The squamous cell carcinoma cell lines Nialym was successfully established from metastatic foci of lymph nodes from a 48-year-old male Japanese patient with squamous cell carcinoma of the tongue. In addition, the Nialymx cell line was established from a transplanted tumor of Nialym cells in SCID mice. Nialym cells were angular, with neoplastic and pleomorphic features. Two types of Nialym cell were observed by electron microscopy; light cells and dark cells. The dark cells had a number of waved tonofilaments in the cytoplasm, while light cells showed poorly developed organelles. The population doubling times for Nialym and Nialymx cells were approximately, 46 and 42 h at the 10th passage. Nialym cells secreted 4.8 ng/ml VEGF and 5.9 ng/ml HGF, Nialymx cells also secreted 6.7 ng/ml VEGF and 4.3 ng/ml HGF at the 10th passage for 3 days of culture. Histopathological aspects of Nialym and Nialymx cell lines were similar. We believe that these cell lines are valuable tools for elucidating the mechanisms of cancer metastasis and developing immunotherapy and chemotherapy regimens.
机译:鳞状细胞癌细胞系Nialym是从一名48岁的日本男性舌鳞癌患者的淋巴结转移灶中成功建立的。另外,从SCID小鼠中的Nialym细胞的移植肿瘤建立了Nialymx细胞系。 Nialym细胞呈角状,具有赘生性和多形性特征。用电子显微镜观察到两种类型的Nialym细胞。亮细胞和暗细胞。深色细胞在细胞质中有许多波形的扁丝,而浅色细胞则显示出发育不良的细胞器。在第10代,Nialym和Nialymx细胞的群体倍增时间分别约为46和42 h。 Nialymx细胞在第10代培养3天时分泌4.8 ng / ml VEGF和5.9 ng / ml HGF,Nialymx细胞也分泌6.7 ng / ml VEGF和4.3 ng / ml HGF。 Nialym和Nialymx细胞系的组织病理学方面相似。我们认为,这些细胞系是阐明癌症转移机制和发展免疫疗法和化学疗法的宝贵工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号